MedImmune Inc. believes that its best days are still to come. Others don?t.
A Maryland-based pharmaceutical company, MedImmune has recently come under fire from one of its major shareholders, Matrix Asset Advisors Inc. Calling for the company to sell itself, Matrix wants MedImmune to market its strengths of a strong development pipeline and several drugs on the market.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
